Guideline Updates G15: GLP-1s in 2026: Obesity as Chronic Disease, Outcomes, and Inpatient Safety

WHO and AACE guidance, semaglutide and tirzepatide landmark trials, complication-targeted prescribing, and what hospitalists must ask when patients present with GI and renal complications.